Clinical Trial Update: A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

View source ↗

Summary

This clinical trial update describes a study of maribavir in adults with kidney failure and CMV infection after transplantation, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• End-stage Renal Disease

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV), Kidney Disease | Status: RECRUITING